Close

Production & Manufacturing

European vaccine development moves forward

The European Vaccine Initiative, a product development partnership supporting the development of vaccines against diseases of poverty, has brought together to Brussels manufacturers, biotech...

Novartis announces agreement to develop influenza vaccines using revolutionary synthetic genomics technology

Novartis announced today an agreement with Synthetic Genomics Vaccines Inc. (SGVI) to apply "synthetic genomics" technologies to accelerate the production of the influenza seed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read